BlackRock Health Sciences Trust - BME Stock Forecast, Price & News

BlackRock Health Sciences Trust's stock was trading at $43.58 at the beginning of 2023. Since then, BME shares have decreased by 6.8% and is now trading at $40.61.
View the best growth stocks for 2023 here.

BlackRock Health Sciences Trust saw a decline in short interest in February. As of February 28th, there was short interest totaling 21,300 shares, a decline of 16.1% from the February 13th total of 25,400 shares. Based on an average daily volume of 29,200 shares, the short-interest ratio is presently 0.7 days.
View BlackRock Health Sciences Trust's Short Interest.

BlackRock Health Sciences Trust announced a monthly dividend on Wednesday, March 1st. Stockholders of record on Wednesday, March 15th will be given a dividend of $0.213 per share on Friday, March 31st. This represents a $2.56 dividend on an annualized basis and a yield of 6.29%. The ex-dividend date is Tuesday, March 14th.
Read our dividend analysis for BME.

Invesco CEF Income Composite ETF holds 113,975 shares of BME stock, representing 0.68% of its portfolio.

BlackRock Health Sciences Trust (NYSE:BME) pays an annual dividend of $2.55 per share and currently has a dividend yield of 0.06%.
Read our dividend analysis for BME.

3 employees have rated BlackRock Health Sciences Trust Chief Executive Officer Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among the company's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and Procter & Gamble (PG).

BlackRock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."

BlackRock Health Sciences Trust's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Nova R Wealth Inc. (0.00%), Wells Fargo & Company MN (0.00%), Morgan Stanley (0.00%), Bank of America Corp DE (0.00%), Advisor Group Holdings Inc. (0.00%) and UBS Group AG (0.00%).
View institutional ownership trends.

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BME stock can currently be purchased for approximately $40.61.

BlackRock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The official website for the company is www2.blackrock.com. The company can be reached via phone at (800) 882-0052.